- Report
- July 2023
- 138 Pages
Global
From €5285EUR$5,500USD£4,544GBP
- Report
- January 2024
- 150 Pages
Global
From €4660EUR$4,850USD£4,007GBP
- Report
- September 2023
- 115 Pages
Global
From €4324EUR$4,500USD£3,718GBP
- Report
- January 2024
- 119 Pages
Europe
From €2388EUR$2,485USD£2,053GBP
€3411EUR$3,550USD£2,933GBP
- Report
- January 2024
- 112 Pages
Asia Pacific
From €2388EUR$2,485USD£2,053GBP
€3411EUR$3,550USD£2,933GBP
- Report
- January 2024
- 110 Pages
North America
From €2388EUR$2,485USD£2,053GBP
€3411EUR$3,550USD£2,933GBP
- Report
- January 2024
- 95 Pages
Middle East, Africa
From €2388EUR$2,485USD£2,053GBP
€3411EUR$3,550USD£2,933GBP
- Report
- June 2023
- 361 Pages
Global
From €5285EUR$5,500USD£4,544GBP
- Report
- May 2024
- 198 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- September 2023
- 216 Pages
Global
From €3060EUR$3,185USD£2,631GBP
€4372EUR$4,550USD£3,759GBP
- Report
- February 2024
- 113 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- January 2024
- 112 Pages
Global
From €4324EUR$4,500USD£3,718GBP
- Report
- February 2024
- 116 Pages
Europe
From €2835EUR$2,950USD£2,437GBP
- Report
- January 2024
- 101 Pages
Asia Pacific
From €2835EUR$2,950USD£2,437GBP
From €2018EUR$2,100USD£1,735GBP
€2883EUR$3,000USD£2,479GBP
- Report
- December 2023
- 351 Pages
Global
From €4129EUR$4,297USD£3,550GBP
- Report
- August 2023
- 255 Pages
Global
From €4611EUR$4,799USD£3,965GBP
From €4799EUR$4,995USD£4,127GBP
- Report
- April 2024
- 270 Pages
Global
From €4804EUR$5,000USD£4,131GBP
Cell and Gene Therapy Manufacturing is a rapidly growing field within the genomics industry. It involves the production of therapeutic cells and genes for use in medical treatments. This includes the production of stem cells, gene-modified cells, and gene-editing tools. The process involves the isolation, expansion, and differentiation of cells, as well as the production of gene-editing tools such as CRISPR-Cas9. The goal is to create therapeutic cells and genes that can be used to treat a variety of diseases.
Cell and Gene Therapy Manufacturing is a highly specialized field, requiring expertise in cell biology, molecular biology, and biochemistry. It also requires the use of advanced technologies such as gene-editing tools, cell culture systems, and bioreactors.
Companies in the Cell and Gene Therapy Manufacturing market include bluebird bio, Cellectis, CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics. These companies are focused on developing and manufacturing therapeutic cells and genes for use in medical treatments. Show Less Read more